15:44:15 EST Wed 04 Nov 2026
Enter Symbol
or Name
USA
CA



Comprehensive Healthcare Systems Inc (2)
Symbol CHS
Shares Issued 32,388,384
Close 2026-11-02 C$ 0.33
Market Cap C$ 10,688,167
Recent Sedar+ Documents

Comprehensive holder Singh acquires 45.67 M shares

2026-11-04 09:39 ET - News Release

Mr. Karan Singh, a shareholder, reports

KARAN PAL SINGH ANNOUNCES AN INCREASE IN HIS OWNERSHIP OF THE COMMON SHARES OF COMPREHENSIVE HEALTHCARE SYSTEMS INC.

On Feb. 27, 2025, and on March 7, 2025, Karan Pal Singh (the acquiror), a controlling shareholder of Comprehensive Healthcare Systems Inc., through the company Nameh Hotels & Resorts Private Ltd. (NHRPL), acquired ownership of 45.67 million shares (2,283,500 postconsolidated shares) at one cent per share (20 cents per postconsolidated share) pursuant to the closing of a non-brokered private placement carried out by the company, for a total cash purchase price of $456,700. On Feb. 12, 2026, 45.67 million shares held by NHRPL were reregistered in the name of the acquiror directly.

Prior to the aforementioned acquisition of shares pursuant to the private placement, the acquiror and Himangini Singh, as joint actor in previous transactions together, through NHRPL, held 17,459,965 shares (872,998 shares postconsolidated) indirectly, nil common share purchase warrants and nil stock options, and the acquiror's and Ms. Singh's non-diluted shareholdings represented approximately 14.08 per cent of the company's issued and outstanding shares.

As a result of the acquisition of shares pursuant to the private placement, as at the end of March, 2025, the acquiror and Ms. Singh, through NHRPL, hold a total of 63,129,965 shares (3,156,498 shares postconsolidated), nil warrants and nil options, and the acquiror's and Ms. Singh's non-diluted shareholdings represent approximately 25.45 per cent of the company's issued and outstanding shares.

To obtain a copy of the early warning report filed by the acquiror, contact the acquiror at 011-91-78382-62067 or refer to the company's SEDAR+ profile.

© 2026 Canjex Publishing Ltd. All rights reserved.